GT is pleased to have achieved a win on behalf of our client Teva Pharmaceuticals USA, Inc.
In May 2018, a U.S. Federal District Court Judge from the Central District
Continue Reading GT Wins Motion to Dismiss for Teva Pharmaceuticals USA, Inc.
A Window to the Legal World for Israeli Companies
GT is pleased to have achieved a win on behalf of our client Teva Pharmaceuticals USA, Inc.
In May 2018, a U.S. Federal District Court Judge from the Central District …
Continue Reading GT Wins Motion to Dismiss for Teva Pharmaceuticals USA, Inc.
Greenberg Traurig’s Tel Aviv office had a breakthrough year in 2015, realizing the vision of bringing together the vibrant Israeli business community with the resources and platforms of a major…
Continue Reading Greenberg Traurig Tel Aviv Year-End Summary
GT had the honor to sponsor a recent Philadelphia event “A Conversation with and Jay Lefkowitz about U.S. & Israeli Relations”. The event, honoring GT client TEVA Pharmaceuticals USA, was…
Continue Reading A Conversation with Alan Dershowitz and Jay Lefkowitz about U.S. & Israeli Relations
In a recent deal that has been reported in press outlets around the globe, Israeli pharmaceuticals company Teva has purchased Mexican counterpart Rimsa for US$2.3 billion. Continue Reading.
Continue Reading Teva buys Mexico’s Rimsa for US$2.3 billion